Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFeD dosing schedules in iron deficiency anemia
NCT03286205Phase 4Withdrawn
- Sponsor
- Sutter Gould Medical Foundation
- Start
- Apr 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iron dextran in iron deficiency anemia (IDA), sponsored by Sutter Gould Medical Foundation. Planned start Apr 2015; status: withdrawn.
02
Drugs
iron dextran
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03286205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03286205.